Advertisement

International Journal of Clinical Oncology

, Volume 23, Issue 2, pp 258–265 | Cite as

Monitoring the estimated glomerular filtration rate (eGFR) in patients with small-cell lung cancer during chemotherapy: equations based on serum creatinine or cystatin C?

  • Xue Tian
  • Xinxing Zhang
  • Min Yu
  • You Lu
  • Zhenyu Ding
  • Meijuan Huang
  • Feng Peng
  • Li Ren
  • Jin Wang
  • Yongsheng Wang
  • Yong Xu
  • Jiang Zhu
  • Lin Zhou
  • Xiaojuan Zhou
  • Min Deng
  • Xin Tang
  • Youling Gong
Original Article
  • 176 Downloads

Abstract

Background

This study compared the differences between the estimated glomerular filtration rate (eGFR) calculated by several equations based on serum creatinine (Scr) and cystatin C (CysC) concentrations for monitoring renal function in patients with small-cell lung cancer (SCLC) during chemotherapy.

Methods

Seventy-one patients with SCLC were retrospectively analyzed. The eGFR before and after each chemotherapy cycle was calculated by the following equations: the chronic kidney disease epidemiology collaboration (CKD-EPI) equation, the modification of diet in renal disease (MDRD) equation, the Cockcroft–Gault (CG) equation, and five CysC-based equations. The patients were compared among the different eGFR groups.

Results

The mean decreases in eGFRCKD-EPI (−2.25 ± 9.89 ml/min/1.73 m2) between each treatment cycle were more significant than the decreases in eGFRCG (−0.46 ± 10.17 ml/min/1.73 m2), eGFRMDRD (−0.48 ± 9.79 ml/min/1.73 m2), and five calculated eGFRCysC (p < 0.05). Single-/multiparameter analyses showed that patients with a higher body mass index (BMI >23) and receiving more treatment cycles (>3) were at increased risk for developing renal impairment with an eGFR less than 60 ml/min/1.73 m2 during chemotherapy.

Conclusions

The eGFR calculated by the CKD-EPI equation changed more significantly between each chemotherapy cycle than did the eGFR from the other equations based on Scr or CysC in patients with SCLC. Oncologists should pay more attention to the renal function of specific patient groups during treatment.

Keywords

Estimated glomerular filtration rate (eGFR) Small-cell lung cancer Chemotherapy CKD-EPI equation 

Notes

Author’s contributions

XT (Xue Tian) and XXZ drafted the manuscript and performed data analysis. JZ, ZYD, XJZ, MY, MD, and XT contributed to the design of the study and collection of data. YL, LR, FP, YX, MJH, JW, YSW, and ZL worked on data collection and critical revision of the manuscript; YLG provided the concept of this study, drafted the manuscript, and gave the final approval of the version to be published. All authors read and approved the final manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

References

  1. 1.
    NCCN clinical practice guidelines in oncology (2017) Small Cell Lung Cancer, www.nccn.org
  2. 2.
    Kapoor M, Chan GZ (2001) Malignancy and renal disease. Crit Care Clin 17:571–598CrossRefPubMedGoogle Scholar
  3. 3.
    da Silva J, Mesler D (2001) Acute renal failure as a result of malignancy. In: Molitoris B, Finn W (eds) Acute renal failure: a companion to Brenner and Rector’s The Kidney. Harcourt, Indianapolis, pp 312–321Google Scholar
  4. 4.
    Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41CrossRefPubMedGoogle Scholar
  5. 5.
    Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461–470CrossRefPubMedGoogle Scholar
  6. 6.
    Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Michels WM, Grootendorst DC, Verduijn M et al (2010) Performance of the Cockcroft–Gault, MDRD, and new CKD-EPI equations in relation to GFR, age, and body size. Clin J Am Soc Nephrol 5:1003–1009CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Abrahamson M, Olafsson I, Palsdottir A et al (1990) Structure and expression of the human cystatin C gene. Biochem J 268:287–294CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Chew JSC, Saleem M, Florkowski CM et al (2008) Cystatin C: a paradigm of evidence-based laboratory medicine. Clin Biochem Rev 29:47–62PubMedPubMedCentralGoogle Scholar
  10. 10.
    Stabuc B, Vrhovec L, Stabuc-Silih M et al (2000) Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy. Clin Chem 46:193–197PubMedGoogle Scholar
  11. 11.
    Thomas F, Seronie-Vivien S, Gladieff L et al (2005) Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin. Clin Pharmacokinet 44:1305–1316CrossRefPubMedGoogle Scholar
  12. 12.
    Benohr P, Grenz A, Hartmann JT et al (2006) Cystatin C: a marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy. Kidney Blood Press Res 29:32–35CrossRefPubMedGoogle Scholar
  13. 13.
    Satariano WA, Ragland DR (1994) The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120:104–110CrossRefPubMedGoogle Scholar
  14. 14.
  15. 15.
    Tan GD, Lewis AV, James TJ et al (2002) Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 25:2004–2009CrossRefPubMedGoogle Scholar
  16. 16.
    Larsson A, Malm J, Grubb A et al (2004) Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 64:25–30CrossRefPubMedGoogle Scholar
  17. 17.
    Grubb A, Björk J, Lindström V et al (2005) A cystatin C-based equation without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft–Gault equation. Scand J Clin Lab Invest 65:153–162CrossRefPubMedGoogle Scholar
  18. 18.
    Grubb A, Nyman U, Björk J et al (2005) Simple cystatin C-based prediction equations for glomerular filtration rate compared with the Modification of Diet in Renal Disease prediction equation for adults and the Schwartz and the Counahan–Barratt prediction equations for children. Clin Chem 51:1420–1431CrossRefPubMedGoogle Scholar
  19. 19.
    Sjöström P, Tidman M, Jones I (2005) Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest 65:111–124CrossRefPubMedGoogle Scholar
  20. 20.
    Levey AS, Coresh J, Greene T et al (2006) Chronic Kidney Disease Epidemiology Collaboration: using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254CrossRefPubMedGoogle Scholar
  21. 21.
    Stevens LA, Coresh J, Feldman HI et al (2007) Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 18:2749–2757CrossRefPubMedGoogle Scholar
  22. 22.
    Wong TY, Tai ES (2009) The CKD-EPI equation and MDRD study equation find similar prevalence of chronic kidney disease in Asian populations. Ann Intern Med 151:892–893CrossRefPubMedGoogle Scholar
  23. 23.
    Lustgarten JA, Wenk RE (1972) Simple, rapid, kinetic method for serum creatinine measurement. Clin Chem 18:1419–1422PubMedGoogle Scholar
  24. 24.
    Poggio ED, Wang XL, Greene T et al (2005) Performance of the modification of diet in renal disease and Cockcroft–Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 16:459–466CrossRefPubMedGoogle Scholar
  25. 25.
    Mojiminiyi OA, Marouf R, Abdella N et al (2002) Serum concentration of cystatin C is not affected by cellular proliferation in patients with proliferative haematological disorders. Ann Clin Biochem 39:308–310CrossRefPubMedGoogle Scholar
  26. 26.
    Bárdi E, Bobok I, Oláh AV et al (2004) Cystatin C is a suitable marker of glomerular function in children with cancer. Pediatr Nephrol 19:1145–1147CrossRefPubMedGoogle Scholar
  27. 27.
    Sokol JP, Schiemann WP (2004) Cystatin C antagonizes transforming growth factor β signaling in normal and cancer cells. Mol Cancer Res 2:183–195PubMedGoogle Scholar
  28. 28.
    Sun Q (1989) Growth stimulation of 3T3 fibroblasts by cystatin. Exp Cell Res 180:150–160CrossRefPubMedGoogle Scholar
  29. 29.
    Tavera C, Leung-Tack J, Prevot D et al (1992) Cystatin C secretion by rat glomerular mesangial cells: autocrine loop for in vitro growth-promoting activity. Biochem Biophys Res Commun 182:1082–1088CrossRefPubMedGoogle Scholar
  30. 30.
    Cox JL, Sexton PS, Green TJ et al (1999) Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin C. Melanoma Res 9:369–374CrossRefPubMedGoogle Scholar
  31. 31.
    Ervin H, Cox JL (2005) Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression. Cancer Cell Int 5:14CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Kos J, Stabuc B, Cimerman N et al (1998) Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem 44:2556–2557PubMedGoogle Scholar
  33. 33.
    Naumnik W, Niklinska W, Ossolinska M et al (2009) Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy. Folia Histochem Cytobiol 47:207–213CrossRefPubMedGoogle Scholar
  34. 34.
    Strojan P, Svetic B, Smid L et al (2004) Serum cystatin C in patients with head and neck carcinoma. Clin Chim Acta 344:155–161CrossRefPubMedGoogle Scholar
  35. 35.
    Mussap M, Plebani M (2004) Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 41:467–550CrossRefPubMedGoogle Scholar
  36. 36.
    Poole SG, Dooley MJ, Rischin D (2002) A comparison of bedside renal function estimates and measured glomerular filtration rate (TC99m-DTPA clearance) in cancer patients. Ann Oncol 13:949–955CrossRefPubMedGoogle Scholar
  37. 37.
    Wright JG, Boddy AV, Highly M et al (2001) Estimation of glomerular filtration rate in cancer patients. Br J Cancer 84:452–459CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2017

Authors and Affiliations

  • Xue Tian
    • 1
  • Xinxing Zhang
    • 1
  • Min Yu
    • 1
  • You Lu
    • 1
  • Zhenyu Ding
    • 1
  • Meijuan Huang
    • 1
  • Feng Peng
    • 1
  • Li Ren
    • 1
  • Jin Wang
    • 1
  • Yongsheng Wang
    • 1
  • Yong Xu
    • 1
  • Jiang Zhu
    • 1
  • Lin Zhou
    • 1
  • Xiaojuan Zhou
    • 1
  • Min Deng
    • 1
  • Xin Tang
    • 1
  • Youling Gong
    • 1
  1. 1.Department of Thoracic Oncology and State Key Laboratory of Biotherapy, Cancer CenterWest China Hospital, Sichuan UniversityChengduPeople’s Republic of China

Personalised recommendations